Skip to main content

Want a detailed portfolio tracker?

ZYBT
NASDAQ
$8.01

Zhengye Biotechnology Holding Ltd (ZYBT)

Zhengye Biotechnology Holding Limited (Ticker: ZYBT) is an innovative biotechnology firm specializing in the development and commercialization of advanced biopharmaceutical products aimed at addressing critical medical needs. With a robust pipeline and proprietary technologies, ZYBT is well-positioned to enhance treatment outcomes across multiple therapeutic areas. The company's commitment to rigorous research and development, coupled with a focus on quality and innovation, underscores its potential for sustainable growth and value creation for investors in the competitive biotechnology landscape.
Website: https://www.jlzybio.com

Market Cap

$35M

P/B Ratio

0.92

Free Cash Flow Yield

4.97%

Beta (5Y)

1.00

Price Chart

Valuation
Market Cap$35M
P/S0.30
P/B0.92
Profitability
Total Revenue (TTM)$17M
Gross Profit (TTM)$3.41M
EBITDA-$6.38M
Profit Margin-60%
Operating Margin-60.6%
EPS-$0.21
Financial Health
Debt-to-Equity4.1%
Free Cash Flow Yield4.97%
Growth & Risk
Beta (5Y)1.00
Sharpe Ratio0.89